Optimised Recovery With Magnesium Oxide After Liver Resection. A Randomised Controlled Trial

Gillissen F, Coolsen M, van Dam R, Bemelmans M, Damink S, Malago M, Neumann U, Dejong C

9th Congress of European-African HPBA (E-AHPBA), April 2011, Cape Town, SA; HPB 13 (2) : 80

Background: The routine use of laxatives after liver surgery as part of an Enhanced Recovery After Surgery (ERAS) programme enhances recovery of gastrointestinal function and early tolerance of oral nutrition. The use of magnesium oxide as laxative during 1 week prior to liver resection could promote early return of gastro-intestinal function and accelerate recovery. Methods: 70 patients programmed for partial liver resection will be randomised to either preoperative laxation with 1000 mg Magnesium oxide daily 1 week prior to surgery until discharge, and postoperative laxation 1000 mg Magnesium oxide daily from the day of surgery until discharge. All patients will be managed within an ERAS programme of perioperative care. Primary outcome measure is recovery of gastro-intestinal function. Secondary outcome measures are functional recovery, length of hospital stay and patient activity level, measured by activPAL activity meter. We estimate that we will require 35 patients in both groups to detect an effect on the mean change in the time to ? rst passage of stools post surgery and functional recovery. (power 80% and ? = 0.05). Discussion: This study is a multicentre RCT that may prove that the use of magnesium oxide during 1 week prior to liver resection leads to earlier return of gastro-intestinal function and accelerates recovery.

NA

Gillissen F, Coolsen M, van Dam R, Bemelmans M, Damink S, Malago M, Neumann U, Dejong C Optimised Recovery With Magnesium Oxide After Liver Resection. A Randomised Controlled Trial 9th Congress of European-African HPBA (E-AHPBA), April 2011, Cape Town, SA; HPB 13 (2) : 80 2011. http://onlinelibrary.wiley.com/doi/10.1111/j.1477-2574.2011.00308.x/abstract.